These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 17610888

  • 21. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
    Kim DH, Wang-Chesebro A, Weinberg V, Pouliot J, Chen LM, Speight J, Littell R, Hsu IC.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1329-34. PubMed ID: 19409728
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries.
    Ohno T, Nakano T, Kato S, Koo CC, Chansilpa Y, Pattaranutaporn P, Calaguas MJ, de Los Reyes RH, Zhou B, Zhou J, Susworo R, Supriana N, Dung TA, Ismail F, Sato S, Suto H, Kutsutani-Nakamura Y, Tsujii H.
    Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1522-9. PubMed ID: 17919839
    [Abstract] [Full Text] [Related]

  • 24. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF, Tseng CJ, Tseng CC, Yu CY, Wu CT, Chen WC.
    Cancer J; 2008 Apr 01; 14(3):200-6. PubMed ID: 18536561
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: a microarray study of RTOG C-0128.
    Zempolich K, Fuhrman C, Milash B, Flinner R, Greven K, Ryu J, Forbes A, Kerlin K, Nichols RC, Gaffney DK.
    Gynecol Oncol; 2008 May 01; 109(2):275-9. PubMed ID: 18299147
    [Abstract] [Full Text] [Related]

  • 27. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H, Kooy H, Trofimov A, Farr J, Munzenrider J, DeLaney T, Loeffler J, Clasie B, Safai S, Paganetti H.
    Radiother Oncol; 2008 Feb 01; 86(2):148-53. PubMed ID: 18237800
    [Abstract] [Full Text] [Related]

  • 28. Deregulation of the G1/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: a case control study.
    Arvanitis DA, Spandidos DA.
    Oncol Rep; 2008 Oct 01; 20(4):751-60. PubMed ID: 18813814
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Ki-67 expression as a predictor of the effectiveness of radiotherapy and of outcome in locally advanced squamous cell carcinoma of the uterine cervix (immunohistochemical study)].
    Kuznetsova ME, Pozharisskiĭ KM, Vinokurova VL, Zharinov GM, Neklasova NIu.
    Vopr Onkol; 2007 Oct 01; 53(2):175-80. PubMed ID: 17663171
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy.
    Kwon GY, Ha H, Ahn G, Park SY, Huh SJ, Park W.
    Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1150-6. PubMed ID: 17692475
    [Abstract] [Full Text] [Related]

  • 35. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
    Ju XZ, Yang JM, Zhou XY, Li ZT, Wu XH.
    Clin Cancer Res; 2008 Jan 15; 14(2):494-501. PubMed ID: 18223224
    [Abstract] [Full Text] [Related]

  • 36. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
    Murakami A, Nakagawa T, Fukushima C, Torii M, Sueoka K, Nawata S, Takeda O, Ishikawa H, Sugino N.
    Oncol Rep; 2008 Jan 15; 19(1):99-104. PubMed ID: 18097581
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Analysis of telomere damage by fluorescence in situ hybridisation on micronuclei in lymphocytes of breast carcinoma patients after radiotherapy.
    Banerjee B, Sharma S, Hegde S, Hande MP.
    Breast Cancer Res Treat; 2008 Jan 15; 107(1):25-31. PubMed ID: 17333339
    [Abstract] [Full Text] [Related]

  • 39. Indications for adjuvant radiotherapy treatment after surgery and novel modalities for treatment.
    Carballo N, González-Cortijo L, González-Martín A, Rojo A, Chiva L.
    Gynecol Oncol; 2008 Sep 15; 110(3 Suppl 2):S41-4. PubMed ID: 18760712
    [Abstract] [Full Text] [Related]

  • 40. How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery?
    Creasman WT, Kohler M, Korte JE.
    Am J Obstet Gynecol; 2009 Sep 15; 201(3):260.e1-3. PubMed ID: 19539891
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.